publication date: Mar. 29, 2019

Guest Editorial

Congress must commit to sustained increases for NCI

Brian HigginsPeter King

By Reps. Brian Higgins (D-NY) & Peter King (R-NY)


Cancer is a relentless disease that impacts millions of Americans.

Just this year more than 1.7 million people in the U.S. are expected to be diagnosed with cancer, and over 600,000 Americans will die from the disease.

Cancer not only impacts individuals and families across the country, but it also costs our economy more than $216 billion annually in direct treatment costs and lost productivity.

But there is hope. Because of previous congressional investment in cancer research, more than 15.5 million American cancer survivors are alive today, and we are enjoying a quarter century of sustained declines in cancer mortality. As of 2016, the cancer death rate for men and women combined has fallen 27 percent from its peak in 1991. This decline translates to about 1.5 percent per year and more than 2.6 million deaths avoided between 1991 and 2016. 

Still America’s investment in cancer research, when factoring in increases in inflation and higher cost of conducting studies, is falling woefully short.

A recent Congressional Research Service review of total funding to the National Institutes of Health between … Continue reading Congress must commit to sustained increases for NCI

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.